{
    "2021-04-26": [
        [
            {
                "time": "2023-10-15",
                "original_text": "Eli Lilly Rated Tops in Innovation, Bristol-Myers Leader in Invention",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Innovation",
                        "Bristol-Myers",
                        "Leader",
                        "Invention"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "Eli Lilly and Company's (NYSE:LLY) CEO Will Probably Have Their Compensation Approved By Shareholders",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "CEO",
                        "Compensation",
                        "Shareholders"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}